Tuesday 07 July 2020

Dutch Seroxat teen users to sue drug maker for side effects

Photo: Jessi Monomen via Wikimedia Commons

More than 20 people who used the anti-depressant Seroxat (paroxetine) in their youth will make a formal claim against the maker GlaxoSmithKline at the end of this month, the Volkskrant said at the weekend.

They say that GSK failed to inform them about the serious psychological side effects of the drug, including aggressive behaviour and an increased risk of suicide.

The SeroxatClaim foundation was set up last year after a Dutchman who took the drug while a youngster successfully sued GSK for the side effects he suffered.

The side effects were not put down to the drug because they were not noted in the information leaflet provided with the medicine, even though GSK was aware of them, the court said.

GSK is appealing against that ruling and declined to comment on the new court case, the Volkskrant said.

In the meantime, the information leaflet has been amended and the drug is no longer prescribed to the under 18s.

In 2012, The United States Department of Justice fined GlaxoSmithKline $3 billion for  withholding data on paroxetine, unlawfully promoting it for under-18s and preparing an article that misleadingly reported the drug was effective in treating adolescent depression.

Thank you for donating to DutchNews.nl

The DutchNews.nl team would like to thank all the generous readers who have made a donation in recent weeks. Your financial support has helped us to expand our coverage of the coronavirus crisis into the evenings and weekends and make sure you are kept up to date with the latest developments.

DutchNews.nl has been free for 14 years, but without the financial backing of our readers, we would not be able to provide you with fair and accurate news and features about all things Dutch. Your contributions make this possible.

If you have not yet made a donation, but would like to, you can do so via Ideal, credit card or Paypal.